|1.||Ursu, Ramona Gabriela: 1 article (04/2014)|
|2.||Dorobăţ, Carmen: 1 article (04/2014)|
|3.||Luca, Mihaela Cătălina: 1 article (04/2014)|
|4.||Iancu, Luminiţa Smaranda: 1 article (04/2014)|
|5.||Vâţă, A: 1 article (04/2014)|
|6.||Luca, A S: 1 article (04/2014)|
|7.||Colombo, Delia: 1 article (01/2014)|
|8.||Simoni, Lucia: 1 article (01/2014)|
|9.||Gargiulo, Anna: 1 article (01/2014)|
|10.||Di Nuzzo, Sergio: 1 article (01/2014)|
01/01/2005 - "In the PD cohort as a whole, the level of HBAbs correlated with Kt/V No new cases of hepatitis B or HBAg positivity occurred in either group. "
06/01/1975 - "[New pathogenetic aspects of hepatitis B in relation to finding HBAg inhibitor in the intestinal mucosa and human feces]."
12/22/1973 - "Stimulation was minimal in the lymphocytes of two out of 15 normal controls, whereas lymphocytes from nine out of 12 patients who had recovered from hepatitis B showed stimulation, as did lymphocytes from five out of 12 laboratory technicians who had been regularly exposed to HBAg but who had no history of hepatitis or signs of it in the previous two years. "
05/17/1976 - "Double sequential counterimmunoelectrophoresis (DCIEP): an improved method for detection of hepatitis-B antigen (HBAg)."
06/01/1993 - "The result showed that BZYQD was significantly better than the Western medicine in improving clinical symptoms and signs, the liver function and serological test of hepatitis B antigen-antibody system (HBAg-Ab system), P < 0.05. "
|2.||Liver Diseases (Liver Disease)
05/17/1976 - "Double sequential counterimmunoelectrophoresis (DCIEP) (an improved method that we have developed) and Ausria II-125I (an indirect solid-phase radioimmunoassay) were compared for HBAg detection in chronic liver diseases. "
06/01/1975 - "However, it is probable that it is not the carrier state of HBAg which enables the liver disease evolution but the liver disease itself enables the cellular immunity disorders that often appear in the course of CAH."
06/01/1975 - "The percentage of HBAg positive subjects among the various classes of liver diseases determined with these techniques is significantly higher than the one remarked by the AA. "
06/01/1975 - "[Incidence of HBAg in various liver diseases (comparison between radioimmunologic methods and methods of passive hemagglutination)]."
06/01/1975 - "The frequency of HBAg and HBAb in chronic liver disease as detected by a very sensitive method rises the question of a possible role of hepatitis B virus in the pathogenesis of the disease."
06/01/1975 - "The investigation of HBAg by RIA appears to be very helpful in the diagnosis and follow-up of viral hepatitis. "
08/06/1978 - "[Cell immunologic studies in viral hepatitis, hepatitis HBAg carriers, and post-hepatitis patients after 21-25 years]."
05/28/1978 - "[Humoral immunological studies in viral hepatitis and in HBAg virus carriers]."
04/01/1984 - "[Identification of hepatitis B antigens in hepatic tissue in various forms of acute hepatitis]."
08/11/1979 - "Follow-up studies showed no instance of hepatitis or seroconversions of HBAg, but there was a small number of conversions of HBAb from negative to positive."
|4.||alpha 1-Antitrypsin Deficiency (alpha 1 Antitrypsin Deficiency)
|5.||Hepatolenticular Degeneration (Wilson's Disease)
|4.||Hepatitis B Surface Antigens (HBsAg)
|6.||Interferon-alpha (Interferon Alfa)
|9.||Alanine Transaminase (SGPT)
|1.||Transplantation (Transplant Recipients)
|2.||Renal Dialysis (Hemodialysis)